期刊文献+

维持性血液透析患者血清脂联素与螺旋CT冠状动脉钙化积分关系的研究 被引量:1

The study of association between serum adiponectin and coronary artery calcification score in maintenance hemodialysis patients
原文传递
导出
摘要 目的探讨维持性血液透析(MHD)患者血清脂联素与螺旋CT冠状动脉钙化积分(CACS)的关系,分析影响MHD患者冠状动脉钙化的危险因素。方法选择27例MHD患者(MHD组)和13例健康体检者(对照组)为研究对象,采用酶联免疫吸附试验法测定血清脂联素,64排螺旋CT扫描心脏计算CACS,同时观察血红蛋白(Hb)、血钙、血磷、钙磷乘积、全段甲状旁腺激素(iPTH)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、白蛋白(Alb)和高敏C反应蛋白(hs-CRP)等。结果MHD组血清脂联素水平[(15.00±7.47)mg/L]明显高于对照组[(2.07±0.83)mg/L],差异有统计学意义(P〈0.01)。MHD组24例(88.9%,24/27)存在不同程度的冠状动脉钙化(CACS〉0分),CACS平均655(0~3570)分,其中11例钙化严重(CACS≥400分)。对照组10例(10/13)存在冠状动脉钙化,CACS平均126(0~731)分,仅1例患者CACS≥400分。秩和检验显示MHD组CACS显著高于对照组,差异有统计学意义(P〈0.05)。CACS≥400分与CACS〈400分的MHD患者透析龄、舒张压、血磷、钙磷乘积和脂联素水平比较差异有统计学意义(P〈0.05或〈0.01)。Spearman相关分析显示,MHD患者CACS与透析龄、血磷、钙磷乘积、血肌酐和脂联素呈正相关(P〈0.01或〈0.05)。多元逐步回归分析显示钙磷乘积是CACS唯一的独立危险因素(P〈0.01)。结论MHD患者冠状动脉钙化严重,与透析龄、血磷、钙磷乘积、血肌酐和脂联素有关。 Objective To investigate the relations between serum adiponectin and coronary artery calcification score (CACS) and to find the risk factors for coronary artery calcification in maintenance hemodialysis(MHD) patients. Methods Twenty-seven MHD patients(MHD group) and 13 healthy persons (control group) were enrolled in this study. The serum adiponectin was measured by enzyme-linked immunosorbent assay method. CACS was calculated by multi-row spiral CT. The circulating parameters such as hemoglobin (Fib) ,calcium, phosphate, calcium-phosphate product,intact parathTroid hormone(iPTi-I ), total cholesterol (TC), low density lipoprotein cholesterol (LDL-C), albumin (Alb), high sensitive C-reactive protein (hs-CRP), and so on were detected. Results The level of serum adiponectin in MHD group [ (15.00 ± 7.47 ) mg/L ] was significantly higher than that in control group [ (2.07 ± 0.83 ) mg/L ], and there was significant difference (P 〈 0.01 ). Coronary artery calcification(CACS 〉 0 score) was observed in 88.9% (24/27) in MHD group and 10/13 in control group. The mean CACS in MHD group was significantly higher than that in control group [655 (0 -3 570) scores vs. 126 (0 -731 )scores] ,and there was significant difference (P 〈 0.05). Eleven MHD patients and 1 healthy person had severe coronary artery calcifications, (CACS≥400 scores). There was significant difference in dialysis duration, diastolic pressure, phosphate calcium-phosphate product and adiponectin (P 〈 0.05 or 〈 0.01 ). Spearman analysis showed that CACS of MHD patients was positively correlated with dialysis duration, phosphate, calcium-phosphate product, serum creatinine and adiponectin (P 〈 0.01 or 〈 0.05). Only calcium-phosphate product remained as independent predictor of CACS in multivariate analysis (P 〈0.01). Conclusion Coronary artery calcification is common in MHD patients and which is correlated with dialysis duration, serum phosphate, calcium-ph
出处 《中国医师进修杂志》 2014年第22期12-15,共4页 Chinese Journal of Postgraduates of Medicine
基金 首都医学发展科研基金(2009-3195)
关键词 肾透析 脂联素 冠状血管 危险因素 钙化 Renal dialysis Adiponectin Coronary vessels Risk factors Calcification
  • 相关文献

参考文献8

  • 1王英,贾艳丽,刘惠兰.维持性血液透析患者血管钙化情况及其与心血管疾病的关系[J].中国医师进修杂志,2009,32(2):1-3. 被引量:2
  • 2Steffes MW, Gross MD, Lee DH, et al. Adiponectin, visceral fat, oxidative stress, and early macrovascular disease: the Coronary Artery Risk Development in Young Adults Study [J]. Obesity (Silver Spring), 2006,14(2) :319-326. 被引量:1
  • 3Shimoyama Y, Tsuruta Y, Niwa T. Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients [J]. J Ren Nutr, 2012,22( 1 ) : 139-142. 被引量:1
  • 4Ciceri P, Volpi E, Brenna I, et al. Combined effects of ascorbic acid and phosphate on rat VSMC osteoblastie differentiation [J]. Nephrol Dial Transplant, 2012,27 ( 1 ) : 122-127. 被引量:1
  • 5Kato A, Odamaki M, Ishida J, et al. Association of high-molecular- weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients[J]. Nephron Clin Pract ,2005,109( 1 ) :c18-24. 被引量:1
  • 6Krajnc M, Pecovnik-Balon B, Hojs R, et al. Comparison of coronary artery calcification and some coronary artery calcification risk factors in patients on haemodialysis and in patients with type 2 diabetes [ J ]. J Int Med Res, 2011,39(3 ) : 1006-1015. 被引量:1
  • 7Srivaths PR, Goldstein SL, Silverstein DM, et al. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients[ J ]. Pediatr Nephrol, 2011, 26(6) : 945-951. 被引量:1
  • 8Block GA, Raggi P, Bellasi A, et al. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients[J]. Kidney Int, 2007,71(5) :438-441. 被引量:1

共引文献1

同被引文献7

  • 1Koukoulaki M, Papachfistou E, Kalogeropoulou C, et al. Increased prevalence and severity of coronary artery calcification in patients with chronic kidney disease stage III and IV [J]. Nephron Extra, 2012,2( 1 ) : 192-204. 被引量:1
  • 2Hujairi NM, Afzali B, Goldsmith DJ. Cardiac calcification in renal patients:what we do and don't know [J]. Am J Kidney Dis, 2004,43 (2): 234-243. 被引量:1
  • 3Steffes MW,Gross MD,Lee DH,et al. Adiponeetin,visceral fat, oxidative stress,and early macrovaseular disease:the Coronary Artery Risk Development in Young Adults Study [J]. Obesity (Silver Spring ), 2006,14 (2) : 319-326. 被引量:1
  • 4Qasim A,Mehta NN,Tadesse MG,et al. Adipokines,insulin resistance,and coronary artery calcification [J]. J Am Coil Cardiol, 2008,52( 3 ) : 231-236. 被引量:1
  • 5Mitsutake R, Miura S, Shiga Y,et al. Is chronic kidney disease associated with coronary artery stenosis or calcification as assessed by multi-detector row computed tomography? [J]. Intern Med, 2008,47(21 ) : 1835-1841. 被引量:1
  • 6Budoff MJ,Rader DJ,Reilly MP,et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) Study [ J ]. Am J Kidney Dis, 2011, 58 ( 4 ) : 519-526. 被引量:1
  • 7Garland JS,Holden RM,Groome PA,et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease [J]. Am J Kidney Dis, 2008,52(5 ) : 849-858. 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部